Safety and Efficacy Study of NGGT002 in PKU Adult Subjects — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy Study of NGGT002 in PKU Adult Subjects — Stella

Recruiting

Back to Phenylketonurias trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui

Key details

Phase

Very early testing

Sponsor

The First Affiliated Hospital of Bengbu Medical University

Enrollment target

~15 participants

Started

March 2023

Primary completion

December 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov